ATS 2019 Virtual Final Program

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION D51 CRITICAL CARE: THE FOUNTAINHEAD - FLUIDS, MONITORING AND MANAGEMENT OF SHOCK 9:15 a.m. - 3:30 p.m. KBHCCD Area E (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitators : S.A. Magder, MD, Montreal, Canada S. Bihari, MD, ATSF, Bedford Park, Australia P781 Fluid Resuscitation Guided by Volume Responsiveness Status Does Not Reduce Morality in Patients with Sepsis: A Systematic Review and Meta Analysis/ R. Ehrman, R.K. Smith, J. Gallien, R. Welch, K. Akers, A. Malik, R. Sherwin, Detroit, MI, p.A6691 P782 Disagreement Between Flotrac ® /vigileo ® System and Bioz ® System for Stroke Volume Variation Measurement for Determining of Fluid Administration: A Preliminary Study/ S.Y. Park, J. Jeong, Y. Choe, S. Kim, S. Park, Y. Lee, H. Lee, Jeonjusi, Korea, Republic of, p.A6692 P783 Comparison of the Shock Index, Modified Shock Index, and Age Shock Index in a Tertiary Hospital/ D. Sotello Aviles, S. Yang, K.M. Nugent, Lubbock, TX, p.A6693 P784 Decreased Change in Stroke Volume in Patients with Sepsis and Septic Shock/ I.S. Douglas, P.M. Alapat, K. Corl, M.C. Exline, L. Forni, A. Holder, D.A. Kaufman, A. Khan, M.M. Levy, G.S. Martin, J. Sahatjian, W. Self, E.J. Seeley, J.A. Weingarten, M. Williams, C. Winterbottom, D. Hansell, Denver, CO, p.A6694 P785 Albumin Administration During Diuresis in Septic Shock Patients Post-Fluid Resuscitation/ J. Ahues, P. Ahues, L.M. Lit, Atlantis, FL, p.A6695 P786 Safety of Early Fluid De-Resuscitation with Loop Diuretic Administration During Active Shock/ B.D. Bissell, J. Riser, A. Kelly, J. Potter, E. Brewington, S. Dhar, P.E. Morris, Lexington, KY, p.A6696 P787 Diuretic Use in Shock: Trend and Outcomes/ G. Bandak, K. Kashani, S. Donthi, N. Andrijasevic, T. Gunderson, O. Gajic, A. Sakhuja, Huntington, WV, p.A6697 P788 Mortality Outcome of Patients in Septic and Hypovolemic Shock Associated with Prolonged Norepinephrine, Phenylephrine, Epinephrine, Vasopressin and/or Dopamine Use/ B. Eperjesiova, J. Bogaard, G. Rubin, M. Ehtesham, A.M. Stone, Southfield, MI, p.A6698 P789 The Effects of Phenylephrine versus Norepinephrine on Heart Rate and Rhythm in Patients with Septic Shock: A Retrospective, Observational Study/ H. Baloch, M.J. Silverberg, S.G. Chulani, A. Rehman, R. Jain, Newark, NJ, p.A6699 Facilitators : D.A. Kaufman, MD, ATSF, New York, NY J.N. McNeill, MD, Boston, MA P790 Experience Using Angiotensin II, a Novel Vasopressor for Distributive Shock, in the Medical Intensive Care Unit/ C.R. Petri, A. Alkazemi, I. Eche, A. Wong, M.M. Hayes, T. Sarge, M.N. Cocchi, Boston, MA, p.A6700 P791 Time to Norepinephrine Initiation in Patients with Fluid-Refractory Shock/ D. Colon Hidalgo, J. Patel, D. Masic, D.J. Park, M.A. Rech, Maywood, IL, p.A6701 P792 Early and Late Cardiovascular Failure in ICU Patients/ E.M. Viglianti, X.Q. Wang, T.J. Iwashyna, Ann Arbor, MI, p.A6702 P793 Fluid Balance Relates to the Clinical Course of Multi-Organ Dysfunction Syndrome and Mortality in Patients with Septic Shock/ T.Y.-T. Lee, A.C.C. Huang, M.C. Ko, S.-M. Lin, Taoyuan, Taiwan, p.A6703 P794 Lactate Levels at 6 Hrs. Is More Prognostic of in Hospital Mortality than A >=50 % Lactate Clearance in Severe Sepsis/ M. Ayad, S. Karanth, B. Patel, Houston, TX, p.A6704 P795 Arterial Catheters May Protect Against Renal Dysfunction in Shock/ H. Singh, J. Safi, L.L. Price, P. LaCamera, J.R. Tedrow, Boston, MA, p.A6705 P796 Impact of Intravenous Volume Resuscitation in Dialysis-Dependent End Stage Renal Disease (ESRD) Patients with Severe Sepsis or Septic Shock/ A.M. Imam, R. Shaikh, S. Ivanovic, K. Fless, V. Ovnanian, F. Rezai, P. Yodice, N. Mistry, Livingston, NJ, p.A6706 P797 Intravenous Crystalloid Composition Does Not Affect Urinary Kidney Injury Molecule-1 Levels Among Critically Ill Adults/ B. Funke, K.E. Jackson, E.D. Siew, C.T. Saunders, J.D. Blume, W.H. Self, T.W. Rice, M.W. Semler, Nashville, TN, p.A6707 P798 Chloride-Liberal Vs Chloride-Restrictive Strategy for Patient in Critical Care Unit. Systemic Review and Meta-Analysis/ T. Said Ahmed, K. Srour, M.T. Awad, F.M. Khateeb, H.A. Badi, M. Taleb, Toledo, OH, p.A6708 BEHAVIORAL • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION D52 SMOKING-ASSOCIATED MODIFIERS OF LUNG DISEASE 9:15 a.m. - 3:30 p.m. KBHCCD Area F (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitators : S. London, MD, DrPH, Research Triangle Park, NC D. Croft, MD, MPH, Rochester, NY E. Dagli, MD, Instabul, Turkey P895 Cardiovascular Disease in Cigarette Smokers Without Evidence of Smoking-Related Lung Disease/ M.F. Ragland, K. Young, G.L. Kinney, B.J. Make, J.E. Hokanson, Aurora, CO, p.A6709 ATS 2019 • Dallas, TX 354 WEDNESDAY • MAY 22